
Chlorthalidone (12.5mg) + Telmisartan (40mg)
Active composition
+1 more active ingredient
Telmisartan selectively blocks angiotensin II receptors, leading to vasodilation and decreased blood pressure.
Medical applications
Macsart CH 40 Tablet is a combination antihypertensive medication containing Telmisartan 40 mg and Chlorthalidone 12.5 mg. Telmisartan is an angiotensin II receptor blocker (ARB) that selectively inhibits the binding of angiotensin II to the AT1 receptor, thereby reducing vasoconstriction and aldosterone secretion, which leads to decreased blood pressure. Chlorthalidone is a thiazide-like diuretic that promotes the excretion of sodium and water by inhibiting sodium reabsorption in the distal convoluted tubules of the kidneys, contributing to volume reduction and further lowering blood pressure. The synergistic action of these two agents provides effective management of hypertension, reducing the risk of cardiovascular events such as stroke and myocardial infarction. Macsart CH 40 is indicated for patients who require combination therapy to achieve optimal blood pressure control when monotherapy is insufficient. It is essential to monitor renal function, electrolytes, and blood pressure regularly during treatment. Contraindications include hypersensitivity to any component, anuria, and severe renal or hepatic impairment. Caution is advised in patients with electrolyte imbalances or gout. This tablet should be used under medical supervision with appropriate dose adjustments based on clinical response.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Macsart CH 40 Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
High Risk
Macsart CH 40 Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Medical Advice
Macsart CH 40 Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Macsart CH 40 Tablet may be needed. Please consult your doctor. Use of Macsart CH 40 Tablet is not recommended in these patients.
Exercise Caution
Macsart CH 40 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Macsart CH 40 Tablet should be used with caution in patients with liver disease. Dose adjustment of Macsart CH 40 Tablet may be needed. Please consult your doctor. Use of Macsart CH 40 Tablet is not recommended in patients with severe liver disease.
Regular Checkup
0 reviews for Macsart CH 40 Tablet

Telmisartan (40mg) + Chlorthalidone (12.5mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Telmisartan selectively blocks angiotensin II receptors, leading to vasodilation and decreased blood pressure.
Medical applications
Macsart CH 40 Tablet is a combination antihypertensive medication containing Telmisartan 40 mg and Chlorthalidone 12.5 mg. Telmisartan is an angiotensin II receptor blocker (ARB) that selectively inhibits the binding of angiotensin II to the AT1 receptor, thereby reducing vasoconstriction and aldosterone secretion, which leads to decreased blood pressure. Chlorthalidone is a thiazide-like diuretic that promotes the excretion of sodium and water by inhibiting sodium reabsorption in the distal convoluted tubules of the kidneys, contributing to volume reduction and further lowering blood pressure. The synergistic action of these two agents provides effective management of hypertension, reducing the risk of cardiovascular events such as stroke and myocardial infarction. Macsart CH 40 is indicated for patients who require combination therapy to achieve optimal blood pressure control when monotherapy is insufficient. It is essential to monitor renal function, electrolytes, and blood pressure regularly during treatment. Contraindications include hypersensitivity to any component, anuria, and severe renal or hepatic impairment. Caution is advised in patients with electrolyte imbalances or gout. This tablet should be used under medical supervision with appropriate dose adjustments based on clinical response.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Macsart CH 40 Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
High Risk
Macsart CH 40 Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Medical Advice
Macsart CH 40 Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Macsart CH 40 Tablet may be needed. Please consult your doctor. Use of Macsart CH 40 Tablet is not recommended in these patients.
Exercise Caution
Macsart CH 40 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Macsart CH 40 Tablet should be used with caution in patients with liver disease. Dose adjustment of Macsart CH 40 Tablet may be needed. Please consult your doctor. Use of Macsart CH 40 Tablet is not recommended in patients with severe liver disease.
Regular Checkup
0 reviews for Macsart CH 40 Tablet















